Affinity Asset Advisors, LLC Portfolio Holdings
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
Affinity Asset Advisors, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $560 Million distributed in 85 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Xenon Pharmaceuticals Inc. with a value of $45.5M, Arcellx, Inc. with a value of $32.4M, Alkermes Plc. with a value of $31.6M, Teva Pharmaceutical Industries LTD with a value of $30.9M, and Verona Pharma PLC with a value of $30.7M.
Examining the 13F form we can see an decrease of $19.2M in the current position value, from $579M to 560M.
Affinity Asset Advisors, LLC is based out at New York, NY
Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.